Korro Bio, Inc. (KRRO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Korro Bio, Inc. reported revenue of $6.39M, up 181.5% from the prior year. The company ran a net loss, with a net margin of -1834.5%. It held $113.51M in total assets against $62.07M in total liabilities.
Key ratios (FY2025)
-1906.4%
Operating margin
-1834.5%
Net margin
-228.0%
Return on equity
+181.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.39M | $2.27M | $0 | — | — | — | — | — | — | — |
| Operating Income | -$121.86M | -$91.91M | -$84.53M | -$59.00M | -$84.03M | -$27.55M | -$20.68M | -$18.94M | -$16.31M | — |
| Net Income | -$117.26M | -$83.58M | -$81.17M | -$58.03M | -$84.69M | -$26.51M | -$18.75M | -$19.17M | -$20.24M | — |
| EPS (Diluted) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | — | — | — | — | — | — |
| Total Assets | $113.51M | $226.24M | $221.66M | $73.74M | $185.36M | $264.72M | $223.22M | $44.55M | — | — |
| Total Liabilities | $62.07M | $65.83M | $51.75M | $8.91M | $54.53M | $72.23M | $55.86M | $4.12M | — | — |
| Shareholders' Equity | $51.44M | $160.41M | $169.91M | -$99.03M | -$42.21M | $192.49M | $167.36M | -$48.28M | -$29.64M | -$9.66M |
| Cash & Equivalents | $21.82M | $55.64M | $166.15M | $36.33M | $79.64M | $220.34M | $200.16M | $42.19M | — | — |
| Operating Cash Flow | -$78.56M | -$60.07M | -$67.28M | -$53.65M | -$76.06M | -$45.19M | $34.22M | -$17.02M | -$14.61M | — |
| Capital Expenditures | $518.0K | $17.90M | $7.84M | $5.14M | $2.91M | $6.67M | $1.06M | $436.0K | $1.86M | — |
| Shares Outstanding | 9.42M | 9.38M | 8.02M | 268.5K | 34.61M | 33.96M | 30.84M | 2.08M | — | — |